Summit plc
By Business Review Editor
PharmaDeals Review: Vol 2008 Issue 92 (Table of Contents)
Published: 8 Feb-2008
DOI: 10.3833/pdr.v2008i92.226 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Summit is a biotechnology company that developed very rapidly and was listed on the AIM segment of the London Stock Exchange...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd




RSS